Dental Practice Valuation Multiples in 2026: What the Numbers Really Mean

Dental-practice owners encounter at least three kinds of valuation multiple: a percentage of collections, a multiple of seller’s discretionary earnings, and a multiple of adjusted EBITDA. All three can be useful. None can be interpreted without knowing what sits beneath it.

“My practice should sell for 80% of collections” is incomplete. So is “DSOs pay five times EBITDA.” Which collection period? Which EBITDA calculation? Which buyer? What practice size? Was the owner replaced at market compensation? What was included in the price?

The best way to use a multiple is to reconstruct the complete claim.

This article focuses on interpreting market multiples and their limitations. For the complete valuation process, including the income, market, and asset approaches, see How to Value a Dental Practice.

What current closed-sale data show

BizBuySell’s national dental-practice benchmark currently covers reported sales from 2021 through 2025:

Reported closed-sale measure	Lower quartile	Median	Average	Upper quartile
Sale price / owner earnings	1.60×	2.48×	2.63×	3.37×
Sale price / revenue	0.51×	0.70×	0.77×	0.86×

The same source reports five-year median revenue of $557,518 and median owner earnings of $149,838 for its sold-practice dataset. It also shows meaningful annual variation: average earnings multiples were 2.17× in 2024 and 3.28× in 2025, while average revenue multiples were 0.59× and 0.87×, respectively. BizBuySell says a disproportionate number of larger practices sold in 2025, which affected that year’s results (BizBuySell dental-practice benchmarks).

This illustrates why an average cannot be treated as a permanent rule. The mix of businesses sold in one year can move the reported multiple even when nothing about your practice has changed.

These data also require caveats. They represent transactions reported through one marketplace, combine locations and dental practice types, and do not disclose a public transaction count on the benchmark page. Real estate and deal-structure treatment may vary. They are useful orientation evidence—not a substitute for relevant local and specialty comparables.

How the collections rule compares

The ADA describes 65%–85% of average collections for the last three years as a rough ballpark estimate. It calls the calculation a starting point and recommends compiling the financial and operating evidence needed to justify the target price (ADA: What Makes a Successful Sale).

A February 2026 ADA News article, citing Panacea Financial’s transaction data, similarly reports that many healthy solo general practices trade at roughly 65%–85% of prior-year collections. The same article cites 3.5×–5.5× EBITDA for those practices, but the article does not publish the sample size, calculation method, or distribution, so that range is better treated as one lender’s recent market observation than as a universal benchmark (ADA News/Panacea Financial).

The ADA collections range and BizBuySell’s 0.51×–0.86× middle 50% overlap substantially. That is reassuring, but it does not mean collections alone determine value. A revenue multiple hides the practice’s expense structure.

Consider two practices with $1 million of collections:

Practice	Normalized owner earnings	70% collections indication	2.5× earnings indication
A	$300,000	$700,000	$750,000
B	$180,000	$700,000	$450,000

The collections method gives the same result. The earnings method exposes a $120,000 difference in annual owner earnings, which becomes a $300,000 difference in indicated value. A buyer and lender will investigate why.

SDE multiples: most relevant to an owner-operator buyer

Seller’s discretionary earnings, or SDE, attempts to capture the total economic benefit available to one working owner. For a solo practice purchased by another dentist who will replace the seller clinically and managerially, this can be a useful lens.

An SDE multiple reflects more than profit. It also reflects the confidence that the profit will continue, the amount of acquisition debt the cash flow can support, and the buyer’s perceived workload and risk.

Factors that may support the stronger end of a range include:

• Consistent collections and earnings;
• Clean, reconcilable financial statements;
• A healthy active-patient and recare base;
• A stable team and documented systems;
• A favorable, transferable lease;
• Maintained technology and equipment;
• Low concentration in one unusual referral source or payer; and
• A transition plan that protects patient and staff continuity.

The reverse conditions may weaken the multiple. A high percentage of owner production can also narrow the buyer pool if the incoming dentist must replicate a demanding clinical mix or schedule.

EBITDA multiples: most relevant when the business must operate beyond the seller

The SEC defines EBITDA as earnings before interest, taxes, depreciation, and amortization and emphasizes that EBITDA is a non-GAAP measure. A calculation with additional adjustments should be labeled adjusted EBITDA, and companies may calculate those adjustments differently (SEC non-GAAP guidance).

For dental-practice valuation, EBITDA becomes more useful when the buyer is purchasing an enterprise that must pay clinicians and managers after the seller departs. An associate-driven group or DSO buyer therefore asks a different question from a dentist planning to work chairside.

The critical adjustment is often owner labor. If the seller generates clinical production and manages the practice, the buyer must estimate the cost of replacing both roles. Calling that cost an “add-back” without then inserting replacement compensation would overstate transferable earnings.

Why a DSO headline multiple can mislead

Larger or strategically attractive groups may command higher adjusted-EBITDA multiples than a solo practice’s SDE multiple. But a larger multiple applied to a smaller, replacement-cost-adjusted earnings base does not automatically produce a higher value.

Suppose a practice reports $500,000 of SDE. After inserting $210,000 of market-based clinical and management compensation for the owner, adjusted EBITDA is $290,000.

• At 2.5× SDE, the indication is $1,250,000.
• At 4.0× adjusted EBITDA, the indication is $1,160,000.

The “higher” multiple produces the lower value because it measures different economics. A real DSO proposal may also divide consideration among cash at closing, contingent payments, a seller employment agreement, or retained equity. Compare complete economics, not just the headline multiple.

Current institutional-buyer commentary also shows why owners should resist treating one advertised range as settled fact. FOCUS Investment Banking published a December 2025 dental article describing 9×–11× EBITDA for platforms and 4.2×–5.1× for add-ons. An April 2026 article from the same firm described 9×–12× for platforms and 5×–8× for add-ons (FOCUS, December 2025; FOCUS, April 2026). Neither page exposes a deal-level dataset or reproducible sample.

These reports are useful as dated evidence of how one investment bank describes the DSO market. Their disagreement—especially on add-ons—is a reason not to merge them into a single “industry standard” or apply them to a small owner-operated practice.

Seven questions to ask before using any multiple

1. What is the earnings definition? Collections, SDE, EBITDA, and adjusted EBITDA are not interchangeable.
2. Does the data reflect asking prices or closed sales? Asking prices are seller expectations; closed sales are market outcomes.
3. What is the date range? Financing conditions, buyer appetite, labor costs, and deal mix change.
4. What practices are represented? General, orthodontic, pediatric, oral-surgery, and multi-location practices may have different economics and buyer pools.
5. What statistic is quoted? A median, simple average, weighted average, and top-quartile result answer different questions.
6. What is included in the price? Real estate, accounts receivable, cash, debt, working capital, earnouts, notes, and equity can distort comparisons.
7. How similar is the subject practice? Size, margin, growth, provider mix, location, lease, technology, payer mix, and owner dependence all matter.

Use multiples as a range, not a verdict

A defensible estimate usually uses at least two methods:

• An earnings-based primary indication;
• A collections or revenue cross-check; and
• Relevant asset and market evidence where available.

If the methods diverge materially, do not average them automatically. Investigate the cause. Common explanations include unusually high or low overhead, incomplete add-backs, under-market rent, deferred capital spending, rapid growth or decline, or a mismatch between SDE and EBITDA.

Use the multiple as a range

Current public evidence places many reported small dental-practice transactions in a broad band around 0.51×–0.86× revenue and 1.60×–3.37× owner earnings, while ADA guidance describes 65%–85% of collections as a rough starting point. Those are context ranges, not promises.

The right multiple is the one supported by the correct earnings definition, comparable practices, the likely buyer, current market conditions, and the actual deal terms.

Get a free practice valuation

Compare a collections indication with an earnings-based range and see which inputs create the largest value difference.

Try PracticeValuator free →

Article sources

• BizBuySell dental-practice valuation benchmarks — reported 2021–2025 closed-sale revenue and owner-earnings multiples.
• ADA: What Makes a Successful Sale — rough 65%–85% three-year collections range and valuation context.
• ADA News: What Are My Financial Paths to Practice Ownership? — Panacea Financial’s 2026 market observations; sample details are not published.
• SEC: Non-GAAP Financial Measures — EBITDA and adjusted-EBITDA terminology.
• IRS valuation job aid — no universally applicable valuation formula.
• FOCUS Investment Banking, December 2025 and April 2026 — dated DSO market commentary; the published add-on ranges conflict and the public pages do not expose transaction samples.